CLINICAL_TRIALS
trial_result
· 2020-05-01
Clinical Trial Update: A Study of LY900014 in Participants With Type 1 Diabetes [Phase 3]
Summary
Phase 3 trial update for LY900014 in Type 1 Diabetes mellitus has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Type 1 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2020-05-01